UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacist-provided rapid HIV testing in two community pharmacies

Journal of the American Pharmacists Association, 2015, Vol.55 (1), p.81-88

2015

Volltextzugriff (PDF)

Point-of-care testing for infectious diseases: Opportunities, barriers, and considerations in community pharmacy

Journal of the American Pharmacists Association, 2014-03, Vol.54 (2), p.163-171

2014

Volltextzugriff (PDF)

Socioeconomic Impact of Seasonal (Epidemic) Influenza and the Role of Over-the-Counter Medicines

Drugs (New York, N.Y.), 2014-09, Vol.74 (13), p.1467-1479

Klepser, Michael E.

2014

Volltextzugriff (PDF)

Consumer interest in community pharmacy HIV screening services

Journal of the American Pharmacists Association, 2015, Vol.55 (1), p.67-72

2015

Volltextzugriff (PDF)

Pharmacy-Based Point-of-Care Testing: How a “Standard of Care” Approach Can Facilitate Sustainability

Innovations in pharmacy, 2021-11, Vol.12 (4), p.16

2021

Volltextzugriff (PDF)

Pharmacist Prescribing Models for HIV Pre-exposure and Post-exposure Prophylaxis

The Annals of pharmacotherapy, 2024-04, Vol.58 (4), p.434-440

2024

Volltextzugriff (PDF)

Pharmacist Prescriptive Authority for Acne: An Evidence-Based Approach to Policy

Innovations in pharmacy, 2021-04, Vol.12 (2), p.11

2021

Volltextzugriff (PDF)

Pharmacy-based CLIA-waived testing in the United States: Trends, impact, and the road ahead

Research in social and administrative pharmacy, 2024-06, Vol.20 (6), p.146-151

2024

Volltextzugriff (PDF)

In Vitro Pharmacodynamics of Amphotericin B, Itraconazole, and Voriconazole against Aspergillus, Fusarium, and Scedosporium spp

Antimicrobial Agents and Chemotherapy, 2005-03, Vol.49 (3), p.945-951

2005

Volltextzugriff (PDF)

Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities

Research in social and administrative pharmacy, 2021-09, Vol.17 (9), p.1574-1578

2021

Volltextzugriff (PDF)

Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness

Journal of the American Pharmacists Association, 2016, Vol.56 (1), p.14-21

2016

Volltextzugriff (PDF)

Pharmacists as important prescribers of coronavirus disease 2019 (COVID-19) antivirals

Antimicrobial stewardship & healthcare epidemiology : ASHE, 2022, Vol.2 (1), p.e112-e112, Article e112

2022

Volltextzugriff (PDF)

Performance of the BD Veritor system SARS-CoV-2 antigen test among asymptomatic collegiate athletes: A diagnostic accuracy study

Exploratory research in clinical and social pharmacy, 2021-09, Vol.3, p.100047-100047, Article 100047

2021

Volltextzugriff (PDF)

In Vitro Activity of Micafungin (FK-463) against Candida spp.: Microdilution, Time-Kill, and Postantifungal-Effect Studies

Antimicrobial Agents and Chemotherapy, 2002-12, Vol.46 (12), p.3846-3853

2002

Volltextzugriff (PDF)

Time and motion study of hepatitis C virus point-of-care testing in community pharmacies

Journal of the American Pharmacists Association, 2023-01, Vol.63 (1), p.435-439

2023

Volltextzugriff (PDF)

The impact of the COVID-19 pandemic on addressing common barriers to pharmacy-based point-of-care testing

Expert review of molecular diagnostics, 2021-08, Vol.21 (8), p.751-755

2021

Volltextzugriff (PDF)

Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods

Antimicrobial Agents and Chemotherapy, 1998-05, Vol.42 (5), p.1207-1212

1998

Volltextzugriff (PDF)

Point-of-care testing in the pharmacy: how is the field evolving?

Expert review of molecular diagnostics, 2018-01, Vol.18 (1), p.5-6

2018

Volltextzugriff (PDF)

Antimicrobial stewardship in outpatient settings: leveraging innovative physician-pharmacist collaborations to reduce antibiotic resistance

Health security, 2015-06, Vol.13 (3), p.166-173

2015

Volltextzugriff (PDF)

Implementation and Evaluation of a Collaborative, Pharmacy-Based Hepatitis C and HIV Screening Program

Preventing chronic disease, 2022-12, Vol.19, p.E83-E83, Article 220129

2022

Volltextzugriff (PDF)

COVID-19 host genetic risk study conducted at community pharmacies: Implications for public health, research and pharmacists’ scope of practice

Research in social and administrative pharmacy, 2023-10, Vol.19 (10), p.1360-1364

2023

Volltextzugriff (PDF)

Evaluation of a community pharmacy–based influenza and group A streptococcal pharyngitis disease management program using polymerase chain reaction point-of-care testing

Journal of the American Pharmacists Association, 2019-11, Vol.59 (6), p.872-879

2019

Volltextzugriff (PDF)

Utilization of influenza and streptococcal pharyngitis point-of-care testing in the community pharmacy practice setting

Research in social and administrative pharmacy, 2018-04, Vol.14 (4), p.356-359

2018

Volltextzugriff (PDF)

Multiplex CLIA-waived point-of-care tests for SARS-CoV-2, influenza A and B, ± other respiratory pathogens: A systematic review

Journal of the American Pharmacists Association, 2024-07, Vol.64 (4), p.102090, Article 102090

2024

Volltextzugriff (PDF)

Pharmacy‐based management of influenza: lessons learned from research

The International journal of pharmacy practice, 2018-12, Vol.26 (6), p.573-578

2018

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(130)

Publikationsform

Sprache

Englisch
(152)

Erscheinungsjahr

n.n

Thema

Science & Technology
(111)
Life Sciences & Biomedicine
(108)
Pharmacology & Pharmacy
(84)
Humans
(80)
Biological And Medical Sciences
(54)
Medical Sciences
(53)
Pharmacology. Drug Treatments
(47)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(42)
Microbial Sensitivity Tests
(30)
Microbiology
(28)
Antifungal Agents
(26)
Infectious Diseases
(26)
Antifungal Agents - Pharmacology
(20)
Antibacterial Agents
(19)
Candida - Drug Effects
(16)
Adult
(15)
Time Factors
(15)
Male
(13)
Candida Albicans
(12)
Female
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacist-provided rapid HIV testing in two community pharmacies

Point-of-care testing for infectious diseases: Opportunities, barriers, and considerations in community pharmacy

Socioeconomic Impact of Seasonal (Epidemic) Influenza and the Role of Over-the-Counter Medicines

Consumer interest in community pharmacy HIV screening services

Pharmacy-Based Point-of-Care Testing: How a “Standard of Care” Approach Can Facilitate Sustainability

Pharmacist Prescribing Models for HIV Pre-exposure and Post-exposure Prophylaxis

Pharmacist Prescriptive Authority for Acne: An Evidence-Based Approach to Policy

Pharmacy-based CLIA-waived testing in the United States: Trends, impact, and the road ahead

In Vitro Pharmacodynamics of Amphotericin B, Itraconazole, and Voriconazole against Aspergillus, Fusarium, and Scedosporium spp

Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities

Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness

Pharmacists as important prescribers of coronavirus disease 2019 (COVID-19) antivirals

Performance of the BD Veritor system SARS-CoV-2 antigen test among asymptomatic collegiate athletes: A diagnostic accuracy study

In Vitro Activity of Micafungin (FK-463) against Candida spp.: Microdilution, Time-Kill, and Postantifungal-Effect Studies

Time and motion study of hepatitis C virus point-of-care testing in community pharmacies

The impact of the COVID-19 pandemic on addressing common barriers to pharmacy-based point-of-care testing

Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods

Point-of-care testing in the pharmacy: how is the field evolving?

Antimicrobial stewardship in outpatient settings: leveraging innovative physician-pharmacist collaborations to reduce antibiotic resistance

Implementation and Evaluation of a Collaborative, Pharmacy-Based Hepatitis C and HIV Screening Program

COVID-19 host genetic risk study conducted at community pharmacies: Implications for public health, research and pharmacists’ scope of practice

Evaluation of a community pharmacy–based influenza and group A streptococcal pharyngitis disease management program using polymerase chain reaction point-of-care testing

Utilization of influenza and streptococcal pharyngitis point-of-care testing in the community pharmacy practice setting

Multiplex CLIA-waived point-of-care tests for SARS-CoV-2, influenza A and B, ± other respiratory pathogens: A systematic review

Pharmacy‐based management of influenza: lessons learned from research

Suchergebnisse filtern